Stock research
Invesco Ltd. IVZ
Delayed Cboe One market data via TradingView. It may differ from primary-exchange or consolidated quotes.
- Ticker
- IVZ
- Exchange
- NYSE
- Sector
- Financials
- Founded
- —
What moves IVZ
Invesco Ltd. sits in Financials. Banks, insurers, asset managers, and exchanges — the plumbing of capital markets, geared directly to interest rates and credit. The forces that matter most for the sector — and therefore for IVZ — are:
- ◆The shape of the yield curve and net interest margins
- ◆Credit quality and loan-loss provisions
- ◆Regulation and capital requirements
- ◆Deal activity and market volatility
Congressional trading in IVZ
| Politician | Trade date | Type | Owner | Amount | Source |
|---|---|---|---|---|---|
| Kevin Hern | 2026-03-17 | Sale | Joint | $15,001 - $50,000 | Filing #20034262 |
Congressional disclosures are delayed, range-based records—not real-time signals or proof of motive. See the source-linked tracker for scope and limitations.
The profile is free
IVZ research stays free. Membership is the living thesis: what we believe, what we’re watching, and when conviction should end.
How Yield Theory covers IVZ
IVZ intersects several of the themes in every Yield Theory issue. We don't chase headlines on individual tickers — we track where capital is rotating and explain what it means for the names in its path.
Compare IVZ with similar companies
More Financials stocks
IVZ — frequently asked questions
What sector is IVZ in?
Invesco Ltd. is classified in the Financials sector and trades on the NYSE.
Do members of Congress trade IVZ?
The current verified House Clerk snapshot contains 1 transaction row for IVZ. Each row below links to the original filing.
Is IVZ a good investment?
We don't publish one-line buy/sell ratings. Yield Theory members get the full macro thesis, catalysts, and risks behind every name we cover, so you can decide with conviction. This page is research, not investment advice.
This page is independent research and educational information, not investment advice or a recommendation to buy or sell any security. Company facts are compiled from public sources. Do your own research.
See whether the IVZ thesis still holds.
This page is company context and filings. Members get one sourced monthly call, a weekly evidence check, and the breakpoint written in advance. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included